6-gingerol (cas 1391-73-7) attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation

Add time:09/06/2019    Source:sciencedirect.com

6-Gingerol, the major component of gingerols extracted from Zingiber officinale, has been shown to exhibit anti-inflammatory and antioxidant bioactivities. Since neuroinflammation plays an important role in neurodegenerative diseases, such as Alzheimer’s disease (AD), and astrocytes have been considered important in the process of neurodegeneration, it was of interest to know whether 6-gingerol reduced astrocytes activation or even attenuated cognitive impairment. Here we examined the neuroprotective effects of 6-gingerol in lipopolysaccharide (LPS)-induced disorder models both in vitro and in vivo. C6 astroglioma cells treated with LPS were found to release excessive pro-inflammatory cytokines, including TNF-α and IL-6, and also increase intercellular ROS, NO, and iNOS (i.e. NOS2). All these were blocked by 6-gingerol in a concentration-dependent manner. The spatial learning and memory of rats challenged with LPS (10 μg, i.c.v.) in the absence or presence of 6-gingerol were evaluated using the Morris water-maze (MWM) test. 6-Gingerol attenuated LPS-induced imapirement of MWM learning and memory in a dose-dependent manner. Besides, 6-gingerol inhibited LPS-induced increases in levels of GFAP and TNF-α in the rat brain. The results suggest that 6-gingerol suppresses astrocyte overactivation, through which it contributes to improvement of cognitive ability.

We also recommend Trading Suppliers and Manufacturers of gingerol (cas 1391-73-7). Pls Click Website Link as below: cas 1391-73-7 suppliers

Prev:Research paperEfficacy and antiparasitic mechanism of 10-gingerol (cas 1391-73-7) isolated from ginger Zingiber officinale against Ichthyophthirius multifiliis in grass carp
Next:Phytosome complexed with chitosan for gingerol (cas 1391-73-7) delivery in the treatment of respiratory infection: In vitro and in vivo evaluation)